Research ArticleOriginal Article
Open Access

First description of plasmid mediated quinolone resistance genes in salmonella isolates from Saudi hospitals

Reem Y. Aljindan, Nasreldin E. Hussein, Hala A. Khoudair, Alaa Y. Shaikh, Hoda A. Hassan, Nawar A. Alabdulqader, Mahmoud A. Shorman and Baha A. Abdalhamid
Saudi Medical Journal July 2018, 39 (7) 685-689; DOI: https://doi.org/10.15537/smj.2018.7.22532

References

  1. ↵
    1. Iwamoto M,
    2. Reynolds J,
    3. Karp BE,
    4. Tate H,
    5. Fedorka-Cray PJ3,
    6. Plumblee JR,
    7. et al.
    (2017) Ceftriaxone-Resistant non-typhoidal Salmonella from humans, retail meats, and food animals in the United States, 1996-2013. Foodborne Pathog Dis 14:74–83.
    OpenUrl
  2. ↵
    1. Liang Z,
    2. Ke B,
    3. Deng X,
    4. Liang J,
    5. Ran L,
    6. Lu L,
    7. et al.
    (2015) Serotypes, seasonal trends, and antibiotic resistance of non-typhoidal Salmonella from human patients in Guangdong Province, China, 2009-2012. BMC Infect Dis 15:53.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Colobatiu L,
    2. Tabaran A,
    3. Flonta M,
    4. Oniga O,
    5. Mirel S,
    6. Mihaiu M
    (2015) First description of plasmid-mediated quinolone resistance determinants and beta-lactamase encoding genes in non-typhoidal Salmonella isolated from humans, one companion animal and food in Romania. Gut Pathog 7:16.
    OpenUrlCrossRef
  4. ↵
    1. Eibach D,
    2. Al-Emran HM,
    3. Dekker DM,
    4. Krumkamp R,
    5. Adu-Sarkodie Y,
    6. Espinoza LM,
    7. et al.
    (2016) The emergence of reduced ciprofloxacin susceptibility in Salmonella enterica causing bloodstream infections in Rural Ghana. Clinical Infectious Diseases 62(Suppl 1):S32–S36.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lee HY,
    2. Su LH,
    3. Tsai MH,
    4. Kim SW,
    5. Chang HH,
    6. Jung SI,
    7. et al.
    (2009) High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother 53:2696–2699.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Kim HB,
    2. Park CH,
    3. Kim CJ,
    4. Kim EC,
    5. Jacoby GA,
    6. Hooper DC
    (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53:639–645.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Park CH,
    2. Robicsek A,
    3. Jacoby GA,
    4. Sahm D,
    5. Hooper DC
    (2006) Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50:3953–3935.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Gay K,
    2. Robicsek A,
    3. Strahilevitz J,
    4. Park CH,
    5. Jacoby G,
    6. Barrett TJ,
    7. et al.
    (2006) Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 43:297–304.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Kim J,
    2. Han X,
    3. Bae J,
    4. Chui L,
    5. Louie M,
    6. Finley R,
    7. et al.
    (2016) Prevalence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with resistance and reduced susceptibility to fluoroquinolones from human clinical cases in Alberta, Canada, 2009-13. J Antimicrob Chemother 71:2988–2990.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Sjölund-Karlsson M,
    2. Howie R,
    3. Rickert R,
    4. Krueger A,
    5. Tran TT,
    6. Zhao S,
    7. et al.
    (2010) Plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates, USA. Emerg Infect Dis 16:1789–1791.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Woodford N,
    2. Fagan EJ,
    3. Ellington MJ
    (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57:154–155.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Gröbner S,
    2. Linke D,
    3. Schütz W,
    4. Fladerer C,
    5. Madlung J,
    6. Autenrieth IB,
    7. et al.
    (2009) Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing. Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58(Pt 7):912–922.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Jacoby GA
    (2009) AmpC beta-lactamases. Clinical microbiology reviews. Clin Microbiol Rev 22:161–182.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Elhadi N,
    2. Aljindan R,
    3. Aljeldah M
    (2013) Prevalence of nontyphoidal. Salmonella serogroups and their antimicrobial resistance patterns in a university teaching hospital in Eastern Province of Saudi Arabia. Infect Drug Resist 6:199–205.
    OpenUrlCrossRefPubMed
  15. ↵
    1. El-Tayeb MA,
    2. Ibrahim AS,
    3. Al-Salamah AA,
    4. Almaary KS,
    5. Elbadawi YB
    (2017) Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia. Braz J Microbiol 48:499–508.
    OpenUrl
  16. ↵
    1. Li B,
    2. Yi Y,
    3. Wang Q,
    4. Woo PC,
    5. Tan L,
    6. Jing H,
    7. et al.
    (2012) Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China. PloS One 7:e42280.
    OpenUrlPubMed
  17. ↵
    1. Rivera IG,
    2. Chowdhury MA,
    3. Huq A,
    4. Jacobs D,
    5. Martins MT,
    6. Colwell RR
    (1995) Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol 61:2898–2904.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Hendriksen RS,
    2. Bangtrakulnonth A,
    3. Pulsrikarn C,
    4. Pornruangwong S,
    5. Noppornphan G,
    6. Emborg HD,
    7. et al.
    (2009) Risk factors and epidemiology of the ten most common Salmonella serovars from patients in Thailand:2002-2007. Foodborne Pathog Dis 6:1009–1019.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Lindgren MM,
    2. Kotilainen P,
    3. Huovinen P,
    4. Hurme S,
    5. Lukinmaa S,
    6. Webber MA,
    7. et al.
    (2009) Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis 15:809–812.
    OpenUrlCrossRefPubMed
    1. Al-Dawodi R,
    2. Farraj MA,
    3. Essawi T
    (2012) Antimicrobial resistance in non-typhi Salmonella enterica isolated from humans and poultry in Palestine. J Infect Dev Ctries 6:132–136.
    OpenUrlPubMed
  21. ↵
    1. Olsen SJ,
    2. Bishop R,
    3. Brenner FW,
    4. Roels TH,
    5. Bean N,
    6. Tauxe RV,
    7. et al.
    (2001) The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997. J Infect Dis 183:753–761.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Xia S,
    2. Hendriksen RS,
    3. Xie Z,
    4. et al.
    (2009) Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan Province, China. J Clin Microbiol 47:401–409.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Lunn AD,
    2. Fabrega A,
    3. Sanchez-Cespedes J,
    4. Vila J
    (2010) Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp clinical isolates. Int Microbiol 13:15–10.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section